Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation

References

• Coulter DL. Comprehensive management of epilepsy in persons with mental retardation. Epilepsia 1997;38(Suppl 4): S24–S31
   Google Scholar
• Pellock J, Morton LD. Treatment of epilepsy in the multiply handicapped. Ment Retard Dev Disabil 2000;6:309–23
   PubMedGoogle Scholar
• Sunder TR. Meeting the challenge of epilepsy in persons with multiple handicaps. J Child Neurol 1997;12(Suppl 1):S38–S43
   Google Scholar
• Alvarez N, Besag F, Iivanainen M. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1988;42(Suppl 1):1–15
   Google Scholar
• Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476–9
   Google Scholar
• Gilliam F, Vazquez B, Sackellares JC, et al. An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 1998;51:1018–25
   PubMed Web of Science ®Google Scholar
• Jawad S, Richens A, Goodwin G, et al. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989;30:356–63
   PubMed Web of Science ®Google Scholar
• Loiseau P, Yuen AWC, Duche B, et al. A randomized double-blind crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res 1990;7:136–45
   PubMed Web of Science ®Google Scholar
• Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284–91
   PubMed Web of Science ®Google Scholar
• Sander JW, Patsalos PN, Oxley JR, et al. A randomized, double-blind, placebo-controlled, add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990;6:221–6
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Dellaportas CI, Findley LJ. Lamotrigine mono-therapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601–7
   Google Scholar
• Frank LM, Enlow T, Holmes GL, et al. Lamictal monotherapy for typical absence seizures in children. Epilepsia 1999;40:973–9
   PubMed Web of Science ®Google Scholar
• Matsuo F. Lamotrigine. Epilepsia 1999;40\(Suppl 5):S30–S36
   Google Scholar
• Motte J, Trevathan E, Arvidsson JF, et al. Lamotrigine for generalized seizures associated with the Lennox–Gastaut syndrome. New Engl J Med 1997;337:1807–12
   PubMed Web of Science ®Google Scholar
• Biton V, Mirza W, Montouris G, et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001;56:172–7
   PubMed Web of Science ®Google Scholar
• Buchanan N. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure 1995;4:233–6
   PubMedGoogle Scholar
• Coppola G, Pascotto A. Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial. Brain Develop 1997;19:398–402
   PubMed Web of Science ®Google Scholar
• Gidal BE, Walker JK, Lott RS, et al. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation. Seizure 2000;9:131–6
   PubMed Web of Science ®Google Scholar
• Huber B, May T, Seidel M. Lamotrigine in multi-handicapped, therapy-resistant epileptic patients. Clin Drug Invest 1998;16:263–77
   Google Scholar
• McKee JR, Sunder TR, FineSmith R, et al. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation. Epilepsy Behav 2003;4:386–94
   PubMed Web of Science ®Google Scholar
• Timmings PL, Richens A. Lamotrigine as an add-on drug in the management of Lennox–Gastaut syndrome. Eur Neurol 1992;32:305–7
   PubMed Web of Science ®Google Scholar
• Veggiotti P, Cieuta C, Rex E, et al. Lamotrigine in infantile spasms. Lancet 1994;344:1375–6
   PubMed Web of Science ®Google Scholar
• Stenbom Y, Tonnby B, Hagberg B. Lamotrigine in Rett syndrome: treatment experience from a pilot study. Eur Child Adolesc Psychiatry 1998;7:49–52
   PubMed Web of Science ®Google Scholar
• Uldall P, Hansen FJ, Tonnby B. Lamotrigine in Rett syndrome. Neuropediatrics 1993;24:339–40
   PubMedGoogle Scholar
• Messenheimer JA, Mullens EL, Giorgi L, et al. Safety review of adult clinical trial experience with lamotrigine. Drug Safety 1998;18:281–96
   PubMed Web of Science ®Google Scholar
• Smith D, Baker G, Davies G, et al. Outcomes of addon treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312–22
   PubMed Web of Science ®Google Scholar
• Coulter DL. Epilepsy and mental retardation: an overview. Am J Ment Retard 1993;98(Suppl):1–11
   Google Scholar
• Singh BK, Towle PO. Antiepileptic drug status in adult outpatients with mental retardation. Am J Ment Retard 1993;98(Suppl):41–6
   Google Scholar
• Vitello SJ, Atthowe Jr JM, Cadwell J. Determinants of community placement of institutionalized mentally retarded persons. Am J Ment Defic 1983;87:539–45
   PubMedGoogle Scholar
• Mirza WU, Credeur LJ, Penry JK. Results of antiepileptic drug reduction in patients with multiple handicaps and epilepsy. Drug Invest 1993;5:320–6
   Google Scholar
• Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1989;30:389–99
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed [revised 1994]. Washington (DC): American Psychiatric Association; 1994
   Google Scholar
• Aman MG, Singh NN, Turbott SH. Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions. Am J Ment Defic 1987;92:237–40
   Google Scholar
• Marshburn EC, Aman MG. Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation. J Autism Dev Disord 1992;22: 357–73
   PubMed Web of Science ®Google Scholar
• Uvebrant P, Bauzien PR. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994;25:284–9
   Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79–88
   PubMed Web of Science ®Google Scholar